PathAI, Bristol Meyers Squibb: Evolving strategic relationship will drive the use of artificial intelligence (AI)-powered pathology in translational research and clinical trials BOSTON — August 25, 2022 — PathAI, a global leader in...

Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions Collaboration builds on commitment to advance personalised healthcare by helping to improve access to new...

Exclusive: combination of drugs causes tumours to vanish in some terminally ill patients, study finds A new cancer treatment can wipe out tumours in terminally ill head and neck cancer patients, scientists have discovered. In a landmark...

A preview of arguments to come After a tedious day of bickering, Victoria Sung appeared like manna from heaven — to tell us that Theranos’ tests sucked. Sung worked at Celgene when it contracted with Theranos. Her testimony was brief and...

February 12-14, 2018   |   Moscone South Convention Center   |   San Francisco, CA Triconference.com/Digital-Pathology Bristol-Myers Squibb and Genentech to Present on Benefits of Multiplex Immunohistochemistry at CHI's Digital...

SAVE THE DATE! DIGITAL PATHOLOGY ASSOCIATION SESSION To take place at the 29th European Congress of Pathology Sunday, September 3, 2017 | 2:45-5:15 PM Amsterdam, The Netherlands Presentations Include: Computational Pathology and...